Today's Information

Provided by: ROSSMAX INTERNATIONAL LTD.
SEQ_NO 10 Date of announcement 2022/05/27 Time of announcement 19:29:22
Subject 
 Announcement on behalf of the subsidiary We Can
Medicines Co. the lifting of non-competition directors
approved by 2022 Annual General shareholder's Metting
Date of events 2022/05/27 To which item it meets paragraph 21
Statement 
1.Date of the shareholders' meeting resolution:2022/05/27
2.Name and title of the managerial officer with permission
 to engage in competitive conduct:
Director:William Cheng
Director:Tsuey-Wen
Director:Mr.JP Liu
Director:Cherry Chang
Director:Ms.Wendland
3.Items of competitive conduct in which the officer is
permitted to engage:Since the main business items are the same as those
of the company.
4.Period of permission to engage in the competitive conduct:
Term of office as director of the company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
Company Act):All shareholders present passed the proposal.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter "N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:N/A
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:N/A
12.Any other matters that need to be specified:NA

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Rossmax International Ltd. published this content on 27 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 May 2022 11:52:23 UTC.